Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05399654
Title A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors (INCLINE-101)
Acronym INCLINE-101
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tallac Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS


No variant requirements are available.